Search for: "Teva Pharmaceuticals" Results 1161 - 1180 of 1,430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2009, 6:45 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? [read post]
27 Jan 2010, 3:00 am
Lupin Ltd. concerning LoSeasonique and Takeda Pharmaceutical Company Limited et al v. [read post]
19 Jan 2011, 2:00 am by Kelly
Highlights this week included: Sensipar (Cinacalcet) – US: District Court Delaware: Obviousness type double patenting does not require later-issued patent with shorter term to abridge term of earlier-granted patent with longer term: Brigham and Women’s Hospital et al v Teva et al (Docket Report) (PatLit) Tarka (Trandolapril / Verapamil) – US: District Court New Jersey: Sanofi, Abbott win trial over Glenmark’s generic Tarka (GenericsWeb) (IPBiz) Please join the… [read post]
2 Oct 2011, 9:03 am
The speaker is Dr Galit Gonen (who heads up the European patent litigation team at Teva Pharmaceuticals) and her subject is "Linkages between legal and marketing theories regarding secondary patents for pharmaceuticals". [read post]
29 Sep 2017, 8:43 am by Kevin S. Little
According to the press release, the following companies are under investigation: Teva, Allergan, Endo, Janssen, Purdue Pharma. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
28 Feb 2023, 12:22 pm by Kevin LaCroix
The top five 2022 North American settlements included Twitter ($809.5 million); Teva Pharmaceutical Industries, Ltd. ($420 million); Luckin Coffee, Inc. ($175 million); BlackBerry Ltd. ($165 million); and NovaStar Mortgage ($165 million). [read post]
2 Sep 2010, 10:21 am by FDABlog HPM
  On September 1st, APP Pharmaceuticals, LLC, which previously submitted an amicus brief in the case (as did Teva Pharmaceuticals - here), filed a Notice of Appeal to the U.S. [read post]
5 Nov 2011, 4:17 am by medmalattorney
In addition to Yaz and Yasmin the Washington Post identified these drosperinone-containing birth control pills: Bayer’s Beyaz and Safyral, Sandoz’s Syeda and Loryna, Barr Laboratories’ Ocella, Watson Pharmaceuticals’ Zarah, and Teva Pharmaceuticals’ Loryna. [read post]
9 Mar 2022, 2:06 pm by Kevin LaCroix
These anticipated 2022 settlements include the $420 million Teva Pharmaceutical settlement; the $175 million Luckin Coffee settlement; the $129 million Granite Construction settlement; and the $100 million Stamps.com settlement. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
25 Nov 2009, 12:00 pm
US: Federal Circuit to hear oral argument in Ajinomoto v ITC 10 December (ITC Law Blog) US: Athena Diagnostics files suits against Ambry Genetics over alleged infringement of patents covering diagnostic technologies (Patent Docs)   Products Dovonex (Calcipotriol) – UK: EWCA (Civ): Follow the instruction or lose the case - Sandoz's attempts at having finding of lack of anticipation overturned fails, appeal dismissed: Leo v Sandoz (IPKat) Famvir (Famciclovir) – US: New Jersey… [read post]
29 Sep 2017, 8:43 am by Kevin S. Little
According to the press release, the following companies are under investigation: Teva, Allergan, Endo, Janssen, Purdue Pharma. [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
12 Oct 2007, 10:03 am
" Claim 1 of the '450 patent is directed to a pharmaceutical composition comprising an ACE inhibitor; "an alkali or alkaline earth metal carbonate"; and a saccharide. [read post]
16 Sep 2011, 8:17 am by Bexis
Teva Pharmaceuticals USA, Inc., 2011 U.S. [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O)   Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
2 Dec 2006, 1:45 pm
In Brussels, they join a notable list of other corporate and government leaders from around the world, including Bertrand Gellie, Director of Pharmaceutical Directorate for the European Patent Office; Georgina Evans, Head of Trade Marks for Shell International Limited; Yehudah Livneh, General Patent Counsel for Teva Pharmaceutical Industries; and Hideo Ozawa, Chief Patent Expert, General Manager Patent Division, Law & Intellectual Property Unit for Fujitsu. [read post]